These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8832970

  • 1. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation.
    Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL.
    J Inflamm; ; 46(1):32-41. PubMed ID: 8832970
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism.
    Kroeger KM, Steer JH, Joyce DA, Abraham LJ.
    Cytokine; 2000 Feb; 12(2):110-9. PubMed ID: 10671295
    [Abstract] [Full Text] [Related]

  • 5. Interactive effects of the tumor necrosis factor promoter and 3'-untranslated regions.
    Han J, Huez G, Beutler B.
    J Immunol; 1991 Mar 15; 146(6):1843-8. PubMed ID: 1848573
    [Abstract] [Full Text] [Related]

  • 6. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients.
    Sohail M, Kaul A, Bali P, Raziuddin M, Singh MP, Singh OP, Dash AP, Adak T.
    Mol Immunol; 2008 Mar 15; 45(6):1682-92. PubMed ID: 17996942
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].
    Aguillón JC, Cruzat A, Cuenca J, Cuchacovich M.
    Rev Med Chil; 2002 Sep 15; 130(9):1043-50. PubMed ID: 12434654
    [Abstract] [Full Text] [Related]

  • 9. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.
    Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW.
    Arthritis Rheum; 2000 Jan 15; 43(1):129-34. PubMed ID: 10643708
    [Abstract] [Full Text] [Related]

  • 10. PMA-responsive 5' flanking sequences of the human TNF gene.
    Hensel G, Meichle A, Pfizenmaier K, Krönke M.
    Lymphokine Res; 1989 Jan 15; 8(3):347-51. PubMed ID: 2779286
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Superantigen-induced transcriptional activation of the human TNF gene promoter in T cells.
    Krämer B, Machleidt T, Wiegmann K, Krönke M.
    J Inflamm; 1995 Jan 15; 45(3):183-92. PubMed ID: 8597873
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection.
    Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD.
    Hum Mol Genet; 2003 Oct 01; 12(19):2541-6. PubMed ID: 12915457
    [Abstract] [Full Text] [Related]

  • 19. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A, Jermendy A, Nagy B, Kovács M, Várkonyi T, Hupuczi P, Prohászka Z, Rigó J.
    Clin Chim Acta; 2008 Jun 01; 392(1-2):52-7. PubMed ID: 18396154
    [Abstract] [Full Text] [Related]

  • 20. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.
    Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B.
    Chin Med J (Engl); 2006 May 05; 119(9):719-24. PubMed ID: 16701011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.